Skip to main content
. Author manuscript; available in PMC: 2022 Mar 18.
Published in final edited form as: J Pediatric Infect Dis Soc. 2020 Feb 28;9(1):30–35. doi: 10.1093/jpids/piy108

Table 1.

Principal Syndromes Among Intracranial GAS Infectionsa

Principal Intracranial Syndrome (No. of Cases) Other Syndrome(s) (n) Age (Range [Median]) Antibiotics Administered (n) No. (%) of Deathsb emm Types (n)c
Meningitis (35) STSS (4); septic arthritis (1); septic shock (1) 4 days-14 years (2.5 years) Third-generation cephalosporins (21); vancomycin (19); ampicillin (7) 6 (17) 1 (10), 12 (4), 89 (3), 4 (2), 28 (2), 118 (2), 9, 11, 49, 59, 77, 87, 122, unknown (5)
ENT infection (34a) (acute otitis media, sinusitis, mastoiditis) STSS (2); septic arthritis (2); septic shock (1) 46 days-15 years (8.6 years) Third-generation cephalosporins (28); vancomycin (26) 3 (9) 1 (9), 6 (4), 5 (2), 12 (2), 3, 4, 18, 59, 75, 118, unknown (11)
VP shunt infection (14) STSS (1) 30 days-10 years (4.6 years) Third-generation cephalosporins (9); vancomycin (13) 0 (0) 12 (3), 28 (2), 1, 2, 3, 11, 44, 75, 86, unknown (2)

Abbreviations: ENT, ear, nose, and throat; GAS, group A Streptococcus; STSS, streptococcal toxic shock syndrome; VP, ventriculoperitoneal.

a

Of a total of 83 patients, which includes children for whom presenting symptoms were available and 2 children for whom presenting symptoms were not available but who had mastoiditis noted in the chart. A supplemental questionnaire was not completed for 8 children; therefore, a determination of principal intracranial syndrome could not be made.

b

Five children who died could not be classified because no information on their symptoms was available.

c

For emm types without a number in parentheses, only 1 isolate with that emm type was found